Sarah Henrickson to Humans
This is a "connection" page, showing publications Sarah Henrickson has written about Humans.
Connection Strength
0.073
-
Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID. J Clin Immunol. 2021 11; 41(8):1745-1747.
Score: 0.008
-
Obesity and immune status in children. Curr Opin Pediatr. 2020 12; 32(6):805-815.
Score: 0.007
-
Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2? Sci Immunol. 2020 04 03; 5(46).
Score: 0.007
-
Adult-Onset Myopathy in a Patient with Hypomorphic RAG2 Mutations and Combined Immune Deficiency. J Clin Immunol. 2018 08; 38(6):642-645.
Score: 0.006
-
Noninfectious Manifestations and Complications of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018 May 09; 7(suppl_1):S18-S24.
Score: 0.006
-
Genomic Circuitry Underlying Immunological Response to Pediatric Acute Respiratory Infection. Cell Rep. 2018 01 09; 22(2):411-426.
Score: 0.006
-
Teaching an old pathway new tricks: Targeting BTK to block NLRP3. Sci Immunol. 2017 11 03; 2(17).
Score: 0.006
-
SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? J Exp Med. 2021 06 07; 218(6).
Score: 0.002
-
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19). J Pediatric Infect Dis Soc. 2021 May 28; 10(5):669-673.
Score: 0.002
-
Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19. J Allergy Clin Immunol Pract. 2021 05; 9(5):2077-2079.e2.
Score: 0.002
-
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol. 2021 03 02; 6(57).
Score: 0.002
-
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020 12 08; 4(23):6051-6063.
Score: 0.002
-
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020 11 02; 130(11):5967-5975.
Score: 0.002
-
Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic. Pediatr Emerg Care. 2020 Nov; 36(11):554-558.
Score: 0.002
-
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome. Pediatr Blood Cancer. 2020 11; 67(11):e28693.
Score: 0.002
-
Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3378-3387.e11.
Score: 0.002
-
Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization. J Allergy Clin Immunol Pract. 2020 09; 8(8):2774-2776.e1.
Score: 0.002
-
Validation of febrile seizures identified in the Sentinel Post-Licensure Rapid Immunization Safety Monitoring Program. Vaccine. 2019 07 09; 37(30):4172-4176.
Score: 0.002
-
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1970-1985.e4.
Score: 0.002
-
Improving allergy office scheduling increases patient follow up and reduces asthma readmission after pediatric asthma hospitalization. Ann Allergy Asthma Immunol. 2018 11; 121(5):561-567.
Score: 0.002
-
Use of Genetic Testing for Primary Immunodeficiency Patients. J Clin Immunol. 2018 04; 38(3):320-329.
Score: 0.002
-
Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis-A Cohort Study. J Invest Dermatol. 2017 06; 137(6):1375-1377.
Score: 0.001
-
Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol. 2005 May; 36(5):494-504.
Score: 0.001